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Methylphenidate (MPD) ,the active ingredient in RitalinTM, is a prescription ADHD stimulant. 
MPD increases levels of dopamine in the synaptic cleft leading to changes with movement and 
reward processing. Given the importance of dopamine signaling during developmental critical 
windows, this study explores neurobiobehavioral alterations resulting from adolescent MPD 
exposure using conditioned place preference (CPP) and behavioral sensitization paradigms. CPP 
involves the development of drug-paired associations to environmental features while 
sensitization tracks motor output in an open field chamber (OFC) that is heightened as a result of 
chronic stimulant exposure. Behavioral sensitization and CPP indicate underlying neural 
circuitry changes and are hallmarks of addiction and future drug susceptibility. We hypothesize 
that adolescent MPD exposure will induce CPP sensitization indicating an increased 
susceptibility to future drug use. We also hypothesize that adolescent exposure to MPD will 
produce sexually dimorphic responses. Adolescent mice began the CPP paradigm with 
habituation on (postnatal day(P22-23)), pre-conditioning (P24-25), conditioning (P26-30), and 
testing for drug-pair chamber preferences (P31). On P90 the persistence of drug-paired chamber 
associations will be assessed using a second CPP test. On P91, the persistence of sensitization to 
stimulant drugs using the OFC will also be assessed. This study shows neurological changes in 
adolescents will sustain into adulthood. These changes also contribute to a female specific cross 
sensitization to Methamphetamine. Clinical implications include a possibility of discontinuing 
MPD prescriptions to females due to increased sensitization or reducing prescription rates of 
medications containing MPD to adolescents until major developmental changes have all 
occurred successfully. 
